Primary results from the Phase II ARACOG (AFT-47) trial, a head-to-head randomized trial conducted by Alliance Foundation Trials LLC, showed that patients treated with NUBEQA® (darolutamide; n=55) ...
Doctors explain the most common causes of hair loss, from stress and thyroid issues to medications, menopause, and nutrient ...
Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We ...
The American Cancer Society estimates about 67,000 new cases of pancreatic cancer will be diagnosed in the U.S. this year and ...
From teeth moving to hair in strange places, ageing can bring with it some unwelcome changes – but many are preventable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results